European Archives - Page 861 of 1099 - European Medical Journal

Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective?

Diabetic macular oedema is a common ocular problem among patients with diabetic retinopathy, that is sight-threatening and leads to blindness

Voluntary Exercise Can Modify the Preference for Palatable Food Through the Modulation of Central Reward Circuit by Peripheral Ghrelin Signal

In obese human subjects, hedonic eating is often present due to palatable foods perhaps promoting addiction in a similar way to drugs.1 It has been…

Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Safe?

Over the last decade, intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents have been increasingly used in the management of various…

Call for Greater Cancer Clinical Trial Eligibility

RECOMMENDATIONS for wider eligibility criteria for cancer clinical trials are being voiced by The American Society of Clinical Oncology (ASCO) and…

New Insights into FANCM Gene Mutations

GENETIC mutations in the FANCM gene were previously thought to be associated with development of Fanconi anaemia, a rare bone marrow disease. Now…

COPD Nutrition: Underutilised and Undervalued!

Some of you may have read my EMJ blog titled ‘The Four Pillars of Living Well with COPD’, which was published last year.

The International Osteoporosis Foundation Continues Campaign to Raise Awareness of Osteoporosis

To mark this year’s World Osteoporosis Day (WOD) on the 20th October 2017, the European Medical Journal spoke to the International Osteoporosis…

This October, EMJ Supports

This October, EMJ has proudly showcased its support for National Cholesterol Month, Stoptober, Wear it Pink, and World Psoriasis Day.

Introducing EMJ Respiratory 5.1

United Kingdom, October 26, 2017: The European Medical Journal welcomes you to the 2017 edition of the EMJ Respiratory eJournal.

Spasmodic Dysphonia: Side Effects of Botox and the Impact on Quality of Life

Spasmodic dysphonia (SD) was described in 1871 as ‘nervous hoarseness’, known as ‘spastic dysphonia’.1 It was not until 1976 that it was acknowledged as…